Global analytics software leader FICO and dacadoo, a global leader in customer engagement via a digital wellness tracking platform and health risk quantification product offering, have partnered to en...
Alliance will give insurers more flexible and precise risk assessment for life insurance, enabling greater targeting and personalized offers
ZURICH & BOZEMAN, Mont.: Global analytics software leader FICO and dacadoo, a global leader in customer engagement via a digital wellness tracking platform and health risk quantification product offering, have partnered to enhance the way insurance companies can assess and manage risk, promote health/wellness, and improve customer engagement. dacadoo will integrate FICO’s advanced AI, analytics and decision management capabilities from FICO® Platform with its health risk quantification risk engine, giving insurers more precise and personalized risk assessments for applicants, helping them better match policies and pricing with each individual.
More information: https://www.fico.com/en/fico-platform
“We have brought to market an innovative solution that enables insurers to target their life insurance products at specific profiles,” said Peter Ohnemus, dacadoo’s president & CEO. “Through our new partnership with FICO, insurers will be able to use more dynamic data to assess the risk of each applicant, and to design highly personalized insurance products for their customers using advanced decision science. They can use the FICO capabilities to enhance their own risk modelling and create more complex decision trees. We are giving insurers a whole new level of risk assessment precision to help them build their portfolio.”
The partnership empowers insurers to shift from traditional, static underwriting models to a dynamic, behavior-based approach — reducing operational costs, enhancing customer loyalty, and improving risk management, all while driving long-term profitability. With over 80% of insurers identifying improved underwriting and customer experience as critical priorities, this collaboration enables key capabilities such as:
The two firms estimate that insurers using their combined solutions could achieve a 20–30% increase in customer lifetime value through personalization and engagement, and a 30–50% reduction in underwriting time via automated, real-time decisioning.
“We see the dacadoo platform as a game-changer,” said Alexandre Graff, vice president for global partners and alliances at FICO. “It not only helps insurers grow their business responsibly, it helps people better manage their health through the digital health engagement platform. We see tremendous opportunities to infuse FICO’s expertise in AI and decision management into dacadoo’s platform and create a better outcome for insurers and individuals.”
About dacadoo
dacadoo is a Swiss-based technology company that develops technology solutions for digital health engagement and health risk quantification. Our Enterprise SaaS based digital health engagement platform (DHEP) is a mobile-first solution that leverages behavioral science, AI, and gamification to help end-users improve their health outcomes while helping clients to improve customer engagement and loyalty through personalization. This platform is available in over 18 languages and can be licensed as a white label offering or through APIs to develop/enhance custom solutions. Our award-winning Risk Engine, which calculates relative risk on mortality and morbidity in real-time, is also available for license through APIs. dacadoo’s global employees are committed to making the world a healthier place. We strongly value security and privacy, with an Information Security and Privacy Management System certified to ISO 27001 and ISO 27701 standards. Learn more: https://www.dacadoo.com/
About FICO
FICO (NYSE: FICO) powers decisions that help people and businesses around the world prosper. Founded in 1956, the company is a pioneer in the use of predictive analytics and data science to improve operational decisions. FICO holds more than 200 US and foreign patents on technologies that increase profitability, customer satisfaction and growth for businesses in financial services, insurance, telecommunications, health care, retail and many other industries. Using FICO solutions, businesses in more than 80 countries do everything from protecting 4 billion payment cards from fraud, to improving financial inclusion, to increasing supply chain resiliency. The FICO® Score, used by 90% of top US lenders, is the standard measure of consumer credit risk in the US and has been made available in over 40 other countries, improving risk management, credit access and transparency.
Learn more at https://www.fico.com
Join the conversation at https://x.com/FICO_corp & https://www.fico.com/blogs/
For FICO news and media resources, visit https://www.fico.com/newsroom
FICO is a registered trademark of Fair Isaac Corporation in the U.S. and other countries.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Paycom Software, Inc. (“Paycom,” “we” and “our”) (NYSE: PAYC), a leading provider of comprehensive, cloud-based human capital management software, today…
Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) (“Mogo” or the “Company”), a digital wealth and payments business, today announced that it will be participating in…
As demand for virtual ADHD care increases, findings from a new study conducted with ADHD 360, the UK’s largest evidence-based digital service specializing…
Nanyang Biologics (NYB) and Precisya Global Inc (PGI) announce a strategic collaboration to leverage our technologies in validating potential therapeutic…